Newer type 2 diabetes drugs show heart protective quality in study
WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data released on Sunday from a so-called real world study sponsored by AstraZeneca. [Source]
Publication Date:Origin: reuters.com
Category: scienceNews
Topics: study, heart, drugs, diabetes, AstraZeneca, sponsored, world, so-called, released, according, disease, medicines, compared, failure, hospitalization, death, significantly, class, newer, (Reuters), WASHINGTON, quality, protective, Newer